CL
ICPT

CSS LLC’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

CSS LLC’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,900
Closed -$781K – 1404
2021
Q4 		$781K Buy
+47,900
New +$807K 0.03% 508
2021
Q2 		– Sell
-5,500
Closed -$127K – 1205
2021
Q1 		$127K Sell
5,500
-2,600
-32% -$72.5K 0.01% 814
2020
Q4 		$200K Buy
8,100
+4,100
+103% +$136K 0.01% 631
2020
Q3 		$166K Sell
4,000
-8,200
-67% -$377K 0.01% 596
2020
Q2 		$585K Buy
12,200
+8,800
+259% +$680K 0.03% 358
2020
Q1 		$214K Sell
3,400
-11,700
-77% -$1.05M 0.02% 421
2019
Q4 		$1.87M Buy
15,100
+14,100
+1,410% +$1.26M 0.1% 171
2019
Q3 		$66K Sell
1,000
-2,200
-69% -$148K ﹤0.01% 533
2019
Q2 		$255K Sell
3,200
-5,800
-64% -$519K 0.01% 405
2019
Q1 		$1.01M Buy
+9,000
New +$983K 0.06% 208
2018
Q1 		– Sell
-2,000
Closed -$117K – 633
2017
Q4 		$117K Hold
2,000
– – 0.01% 539
2017
Q3 		$116K Buy
+2,000
New +$215K 0.01% 549

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

CSS LLC's ICPT Position: Q2 2022 in Review

CSS LLC sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2022, closing a stake of 5,000 shares — an estimated $81K sold.

CSS LLC first reported a position in ICPT in Q1 2017 and held it in 8 quarters. The position peaked at $549K in Q4 2017. 144 funds tracked by Wall St. Rank hold ICPT as of Q2 2022.

  • CSS LLC reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • CSS LLC sold 5,000 Intercept Pharmaceuticals, Inc. shares in Q2 2022, an estimated $81K.
  • CSS LLC first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 8 quarters.
  • CSS LLC's Intercept Pharmaceuticals, Inc. position peaked at $549K in Q4 2017.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2022.

Based on CSS LLC's 13F filing for Q2 2022, filed 15 Aug 2022.